| NCT ID | NCT06984081 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Infertility, Female |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-11-10 |
| Primary Completion | 2030-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-11-10 with a primary completion date of 2030-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In vitro oocyte maturation (IVM) is a mild-approach assisted reproductive technology (ART). Because of its simplicity, the more favorable financial implications (reduced cost) for patients, and the lower health risk profile of IVM compared to controlled ovarian stimulation (COS) in polycystic ovary syndrome (PCOS) patients, the use of IVM in selected patients may gain increasing interest. Besides its application in patients with polycystic ovaries, IVM technology may have a role in fertility preservation, where young girls and adult women are facing infertility due to gonadotoxic chemotherapeutic treatment.
Eligibility Criteria
Inclusion Criteria: * Patients aged from 0-50 years old * Patients seek fertility preservation services * Patients seek oocyte retrieval services Exclusion Criteria: -Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Contact & Investigator
Pui Wah Jacqueline Chung
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT06984081 clinical trial?
This trial is open to female participants only, aged 0 Months or older, up to 50 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06984081 currently recruiting?
Yes, NCT06984081 is actively recruiting participants. Contact the research team at jacquelinechung@cuhk.edu.hk for enrollment information.
Where is the NCT06984081 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06984081 clinical trial?
NCT06984081 is sponsored by Chinese University of Hong Kong. The principal investigator is Pui Wah Jacqueline Chung at Chinese University of Hong Kong. The trial plans to enroll 100 participants.